PPT-The New FTC Platform
Author : sherrill-nordquist | Published Date : 2016-03-07
Connecting your legacy hardware By Team 6389 The Lazybotts 20152016 Season Outline The new platform What changes The new Modern Robotics modules Connecting legacy
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "The New FTC Platform" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
The New FTC Platform: Transcript
Connecting your legacy hardware By Team 6389 The Lazybotts 20152016 Season Outline The new platform What changes The new Modern Robotics modules Connecting legacy hardware The whole new system. Emma Kazaryan . Street Law . Introduction to Consumer Law. Consumers are people who buy or use goods or services. In the US federal and state laws exist to protect consumers from businesses that want to trick or take advantage of them. Overview of the . Division of Financial Practice’s Auto Program. September 2013. Division . of . Financial Practices. Bureau of Consumer . Protection. Teresa Chen Kosmidis. Staff Attorney. The FTC enforces various consumer protection laws, including the FTC Act, which prohibits unfair and deceptive trade practices. Chapter Objectives. After reading this chapter you should be able to. :. Appreciate the role of marketing communications in environmental (green) marketing and sustainability.. Recognize the principles that apply to all green . (Connecting your legacy hardware). By Team #6389 - . The Lazybotts. 2015-2016 Season. Outline. The new platform - What changes?. The new Modern Robotics modules. Connecting legacy hardware. The whole new system. STRATEGY-PI . Study. STRATEGY-NNRTI . Study. Design. Endpoints. Primary: proportion of patients maintaining HIV RNA < 50 c/mL at W48 (mITT, snapshot) ; non-inferiority if lower margin of a two-sided 95% CI for the difference = -12%, 85% power. If non-inferiority and lower margin > 0, assessment for superiority. A Presentation by FTC Team 6022. Rockwell Automation Kickoff. September 12. th. , 2015. What’s New?. Android-Based Control Platform with Cell Phones. Replaces NXT/Samantha Control System. Robot Controller Phone is Mounted to Robot and Connected to Core Module. Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials Andrew Hill, Francois Venter, Eric Delaporte , Simiso Sokhela, Charles kindly visit us at www.examsdump.com. Prepare your certification exams with real time Certification Questions & Answers verified by experienced professionals! We make your certification journey easier as we provide you learning materials to help you to pass your exams from the first try. Professionally researched by Certified Trainers,our preparation materials contribute to industryshighest-99.6% pass rate among our customers. Study 1249. Elvitegravir-Cobicistat-TAF-FTC in HIV/HBV Coinfection . Study 1249: . Design. Source: Gallant J, et al. . J. . Acquir. Immune . Defic. . Syndr. . 2016;73:294-8.. Baseline ART. (n = 72). GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . versus . DTG + TDF-FTC as Initial ART. GEMINI 1 and 2: Background. Source: Cahn P, et al. Lancet. 2019;393:143-55.. Study Design: GEMINI 1 and 2. Background. FTC. Study 311-1089. Switching from TDF/FTC to TAF/. FTC. Study 311: Design. Source. : Gallant JE, et al. Lancet HIV. 2016;3:e158-65.. Switch to TAF/FTC*. . (n = 333). Continue TDF/FTC. (n = 330). *Patients on a pharmacokinetic booster (ritonavir) received tenofovir alafenamide-emtricitabine 10/200 mg. iPrEx. Trial . Substudy. TDF-FTC versus Placebo as HIV . PrEP. for Transgender Women. iPrEx. . Substudy. : Study Design. Source: Deutsch MB, et al. Lancet HIV. 2015;2:e512-9.. Background. : . Subgroup analysis of the . Andrew Hill, Francois Venter, Eric . Delaporte. , . Simiso. Sokhela, Charles . Kouanfack. , . Michelle Moorhouse. , Kaitlyn McCann, Bryony Simmons. , . Alexandra . Calmy. Disclosures. Speaker fees and honoraria from Gilead Sciences, AbbVie, Cipla, Johnson and Johnson, Sanofi, Pfizer, ViiV Healthcare, Mylan and Southern African HIV Clinicians Society. SWEET Trial . Switch to Efavirenz + TDF-FTC . SWEET: Study Design. Source: Fisher M, et al. . J Acquir Immune Defic Syndr. 2009;51:562-8.. Background. : Randomized, . controlled, open-label, phase 3 trial evaluating a simplification strategy for patients suppressed .
Download Document
Here is the link to download the presentation.
"The New FTC Platform"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents